Raily Aesthetic Medicine International Holdings (HKSE:02135) EV-to-EBITDA : -4.26 (As of Jun. 19, 2024)

Raily Aesthetic Medicine International Holdings EV-to-EBITDA Chart

Raily Aesthetic Medicine International Holdings Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial							-75.51	-	67.55	-	-

Competitive Comparison of Raily Aesthetic Medicine International Holdings's EV-to-EBITDA

For the Medical Care Facilities subindustry, Raily Aesthetic Medicine International Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raily Aesthetic Medicine International Holdings's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raily Aesthetic Medicine International Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Raily Aesthetic Medicine International Holdings's EV-to-EBITDA falls into.

Raily Aesthetic Medicine International Holdings EV-to-EBITDA Calculation

Raily Aesthetic Medicine International Holdings's EV-to-EBITDA for today is calculated as:

Raily Aesthetic Medicine International Holdings's current Enterprise Value is HK$90.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Raily Aesthetic Medicine International Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-21.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raily Aesthetic Medicine International Holdings  (HKSE:02135) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Raily Aesthetic Medicine International Holdings's PE Ratio for today is calculated as:

Raily Aesthetic Medicine International Holdings's share price for today is HK$0.138.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Raily Aesthetic Medicine International Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-0.074.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Raily Aesthetic Medicine International Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Raily Aesthetic Medicine International Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Raily Aesthetic Medicine International Holdings (HKSE:02135) Business Description